David Cocke
Director of Finance/CFO at TISSUE REGENIX GROUP PLC
Net worth: 54 833 $ as of 29/04/2024
David Cocke active positions
Companies | Position | Start | End |
---|---|---|---|
TISSUE REGENIX GROUP PLC | Director/Board Member | 20/01/2021 | - |
Director of Finance/CFO | 20/01/2021 | - |
Career history of David Cocke
Former positions of David Cocke
Companies | Position | Start | End |
---|---|---|---|
APERION BIOLOGICS, INC. | Director of Finance/CFO | 31/08/2008 | 31/12/2016 |
NUTECH, INC. | Director of Finance/CFO | 31/10/1993 | 30/04/1996 |
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Kinetic Concepts, Inc. develops advanced wound care solutions and therapies designed to deliver positive outcomes for patients and healthcare professionals. It operates business through two segments: Active Healing Solutions and LifeCell. The Active Healing Solutions segment is focused on the development and commercialization of advanced wound care therapies primarily based on its negative pressure technology platform. The LifeCell segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in reconstructive, cosmetic, orthopedic and urogynecologic surgical procedures to repair soft tissue defects, as well as for reconstructive and cosmetic procedures. It has offices in Africa, Asia Pacific, Australia, Caribbean, Europe, Latin America, Middle East and North America. The company was founded by James R. Leininger in 1976 and is headquartered in San Antonio, TX. | Chief Operating Officer | 31/12/1992 | 31/12/1995 |
Director of Finance/CFO | 31/12/1992 | 31/12/1995 | |
NuPak Medical Ltd.
NuPak Medical Ltd. Miscellaneous Commercial ServicesCommercial Services NuPak Medical Ltd. is an American company that specializes in the development of prototypes, testing, injection molding, and packaging services. The private company's focus is on providing these services to its clients. | Corporate Officer/Principal | - | - |
Training of David Cocke
The University of Texas at Austin | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Statistics
International
United States | 7 |
United Kingdom | 2 |
Operational
Director of Finance/CFO | 4 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NUTECH, INC. | Commercial Services |
TISSUE REGENIX GROUP PLC | Health Technology |
Private companies | 3 |
---|---|
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Kinetic Concepts, Inc. develops advanced wound care solutions and therapies designed to deliver positive outcomes for patients and healthcare professionals. It operates business through two segments: Active Healing Solutions and LifeCell. The Active Healing Solutions segment is focused on the development and commercialization of advanced wound care therapies primarily based on its negative pressure technology platform. The LifeCell segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in reconstructive, cosmetic, orthopedic and urogynecologic surgical procedures to repair soft tissue defects, as well as for reconstructive and cosmetic procedures. It has offices in Africa, Asia Pacific, Australia, Caribbean, Europe, Latin America, Middle East and North America. The company was founded by James R. Leininger in 1976 and is headquartered in San Antonio, TX. | Health Technology |
NuPak Medical Ltd.
NuPak Medical Ltd. Miscellaneous Commercial ServicesCommercial Services NuPak Medical Ltd. is an American company that specializes in the development of prototypes, testing, injection molding, and packaging services. The private company's focus is on providing these services to its clients. | Commercial Services |
Aperion Biologics, Inc.
Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
- Stock Market
- Insiders
- David Cocke
- Experience